These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


480 related items for PubMed ID: 16310434

  • 21. The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans.
    Mori TA, Woodman RJ.
    Curr Opin Clin Nutr Metab Care; 2006 Mar; 9(2):95-104. PubMed ID: 16477172
    [Abstract] [Full Text] [Related]

  • 22. Highly purified omega-3 polyunsaturated fatty acids are effective as adjunct therapy for secondary prevention of myocardial infarction.
    Verboom CN, Critical Analysis of GISSI-Prevenzione Trial.
    Herz; 2006 Dec; 31 Suppl 3():49-59. PubMed ID: 17575805
    [Abstract] [Full Text] [Related]

  • 23. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
    Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T, Basun H, Faxén-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J.
    Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
    [Abstract] [Full Text] [Related]

  • 24. [The role of omega-3 fatty acids in the treatment of bipolar disorders: the current situation].
    Sempels C, Sienaert P.
    Tijdschr Psychiatr; 2007 Oct; 49(9):639-47. PubMed ID: 17853373
    [Abstract] [Full Text] [Related]

  • 25. The Mediterranean diet in secondary prevention of coronary heart disease.
    de Lorgeril M, Salen P.
    Clin Invest Med; 2006 Jun; 29(3):154-8. PubMed ID: 17058434
    [Abstract] [Full Text] [Related]

  • 26. Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids.
    Leaf A.
    Fundam Clin Pharmacol; 2006 Dec; 20(6):525-38. PubMed ID: 17109646
    [Abstract] [Full Text] [Related]

  • 27. Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention.
    Russo GL.
    Biochem Pharmacol; 2009 Mar 15; 77(6):937-46. PubMed ID: 19022225
    [Abstract] [Full Text] [Related]

  • 28. Omega-3 polyunsaturated fatty acids in the treatment of kidney disease.
    Fassett RG, Gobe GC, Peake JM, Coombes JS.
    Am J Kidney Dis; 2010 Oct 15; 56(4):728-42. PubMed ID: 20493605
    [Abstract] [Full Text] [Related]

  • 29. [The role of omega-3 fatty acids from fish in prevention of cardiovascular diseases].
    Reiner E, Tedeschi-Reiner E, Stajminger G.
    Lijec Vjesn; 2007 Oct 15; 129(10-11):350-5. PubMed ID: 18257336
    [Abstract] [Full Text] [Related]

  • 30. n-3 PUFAs and cardiovascular disease prevention.
    Manerba A, Vizzardi E, Metra M, Dei Cas L.
    Future Cardiol; 2010 May 15; 6(3):343-50. PubMed ID: 20462340
    [Abstract] [Full Text] [Related]

  • 31. [Alpha-linolenic acid, cardiovascular disease and sudden death].
    Landmark K, Alm CS.
    Tidsskr Nor Laegeforen; 2006 Nov 02; 126(21):2792-4. PubMed ID: 17086218
    [Abstract] [Full Text] [Related]

  • 32. How relevant is the ratio of dietary n-6 to n-3 polyunsaturated fatty acids to cardiovascular disease risk? Evidence from the OPTILIP study.
    Griffin BA.
    Curr Opin Lipidol; 2008 Feb 02; 19(1):57-62. PubMed ID: 18196988
    [Abstract] [Full Text] [Related]

  • 33. Omega-3 fatty acids in the prevention-management of cardiovascular disease.
    Simopoulos AP.
    Can J Physiol Pharmacol; 1997 Mar 02; 75(3):234-9. PubMed ID: 9164707
    [Abstract] [Full Text] [Related]

  • 34. Assessment of the impact of fibrates and diet on survival and their cost-effectiveness: evidence from randomized, controlled trials in coronary heart disease and health economic evaluations.
    Montagne O, Vedel I, Durand-Zaleski I.
    Clin Ther; 1999 Nov 02; 21(11):2027-35. PubMed ID: 10890271
    [Abstract] [Full Text] [Related]

  • 35. Fatty acid facts, Part III: Cardiovascular disease, or, a fish diet is not fishy.
    Pauwels EK, Kostkiewicz M.
    Drug News Perspect; 2008 Dec 02; 21(10):552-61. PubMed ID: 19221636
    [Abstract] [Full Text] [Related]

  • 36. Mediterranean diet and n-3 fatty acids in the prevention and treatment of cardiovascular disease.
    de Lorgeril M, Salen P.
    J Cardiovasc Med (Hagerstown); 2007 Sep 02; 8 Suppl 1():S38-41. PubMed ID: 17876197
    [Abstract] [Full Text] [Related]

  • 37. Understanding omega-3's.
    DeFilippis AP, Sperling LS.
    Am Heart J; 2006 Mar 02; 151(3):564-70. PubMed ID: 16504616
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Modulation of enzymatic activities by n-3 polyunsaturated fatty acids to support cardiovascular health.
    Siddiqui RA, Harvey KA, Zaloga GP.
    J Nutr Biochem; 2008 Jul 02; 19(7):417-37. PubMed ID: 17904342
    [Abstract] [Full Text] [Related]

  • 40. Omega-3 (n-3) fatty acids, cardiovascular disease and stability of atherosclerotic plaques.
    Calder PC, Yaqoob P.
    Cell Mol Biol (Noisy-le-grand); 2010 Feb 25; 56(1):28-37. PubMed ID: 20196967
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 24.